<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04702061</url>
  </required_header>
  <id_info>
    <org_study_id>Esogu Anesthesia</org_study_id>
    <nct_id>NCT04702061</nct_id>
  </id_info>
  <brief_title>Comparison of Erector Spina Plane Block and Thoracic Epidural Block</brief_title>
  <official_title>Comparison of Erector Spina Plane Block and Thoracic Epidural Block in Breast Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inonu University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Inonu University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this randomised controlled and double-blind study, is to compare the effects of&#xD;
      erector spinae plane (ESP) and thoracic epidural (TEA) blocks on peri-operative hemodynamics&#xD;
      and analgesia in patients undergoing unilateral mastectomies due to malignancy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be randomised into two groups as Group E (those who received general anesthesia&#xD;
      after the erector spina plan block) and Group T (those who received general anesthesia after&#xD;
      thoracic epidural block).&#xD;
&#xD;
      After the block skin conductivity (galvanic skin response - GSR), body temperature changes,&#xD;
      sympathetic and sensory block levels, peri-operative hemodynamic data, postoperative pain&#xD;
      scores and analgesic consumption will be recorded.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 11, 2021</start_date>
  <completion_date type="Actual">March 31, 2021</completion_date>
  <primary_completion_date type="Actual">March 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sympathetic block level evaluation with skin conductivity</measure>
    <time_frame>45 minutes after block administration</time_frame>
    <description>Skin conductivity will be measured by galvanic skin response (GSR)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sympathetic block level evaluation with skin temperature</measure>
    <time_frame>45 minutes after block administration</time_frame>
    <description>Skin temperature of bilateral thorax will be measured</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sympathetic block level evaluation with hot cold test</measure>
    <time_frame>45 minutes after block administration</time_frame>
    <description>Hot cold test of bilateral thorax will be measured</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sympathetic block level evaluation by hemodynamic data</measure>
    <time_frame>45 minutes after block administration</time_frame>
    <description>Peri-operative heart rate and mean arterial pressure will be recorded</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sensorial block level evaluation</measure>
    <time_frame>45 minutes after block administration</time_frame>
    <description>By pin-prick test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>intraoperative hemodynamic data</measure>
    <time_frame>During the operation</time_frame>
    <description>Heart rate and mean arterial pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain scores</measure>
    <time_frame>24 hours after operation</time_frame>
    <description>Pain score will be measured with visual analog scale (0-no pain; 10-worst pain) during movement and rest.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rescue analgesics consumption</measure>
    <time_frame>During the operation and 24 hours after operation</time_frame>
    <description>Amount of remifentanil (microgram)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rescue analgesics consumption</measure>
    <time_frame>24 hours after operation</time_frame>
    <description>Amount of tramadol (milligram)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Breast Neoplasms</condition>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Group E</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients who receive general anesthesia after erector spina plane block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group T</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients who receive general anesthesia after thoracic epidural block</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Erector spina plane block before general anaesthesia</intervention_name>
    <description>After skin infiltration with 2 ml of 2% lidocaine, an 18 G tuohy needle will be directed between the erector spina muscle and the transverse process of the T4 vertebra using the in-plane technique. The location of the needle will be confirmed by hydrodissection with saline after touching the transverse process. After the plan open, 5 ml of 2% lidocaine, 10 ml of 0.5% bupivacaine and 10 ml of saline, including hydrodissection, will be given in a total amount of 25 ml. Then a 20-G epidural catheter will be inserted 3-4 cm and fixed.</description>
    <arm_group_label>Group E</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Thoracic epidural block before general anaesthesia</intervention_name>
    <description>After skin infiltration with 2 ml of 2% lidocaine, an 18 G tuohy needle will be entered through the T4-5 interspinous space (median or paramedian approach). After reaching the thoracic epidural area by loss of resistance method, the epidural catheter will be advanced and fixed to remain 3-4 cm in the epidural area. Following the test dose (2 ml of 2% lidocaine), 3 ml of 2% lidocaine, 5 ml of 0.5% bupivacaine and 5 ml of saline will be administered intermittently in a total volume of 15 ml.</description>
    <arm_group_label>Group T</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ASA(American Society of Anesthesiologist) physical classification I-III&#xD;
&#xD;
          -  Patients undergoing unilateral mastectomies due to malignancy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Active infection at the intervention site&#xD;
&#xD;
          -  History of coagulopathy or anticoagulant use (less time has passed before peripheral&#xD;
             and central blocks)&#xD;
&#xD;
          -  Major cardiac, pulmonary, renal and neurological diseases&#xD;
&#xD;
          -  Autonomic neuropathy or use of drugs that affect autonomic function&#xD;
&#xD;
          -  Patients with type 1 diabetes or insulin dependent type 2 diabetes over 10 years&#xD;
&#xD;
          -  Allergic to local anesthetics;&#xD;
&#xD;
          -  Patients who are uncooperative or have psychiatric problems&#xD;
&#xD;
          -  Morbidly obese (body mass index &gt; 35 kg/m2)&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gulay ERDOGAN KAYHAN, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor Doctor</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Eskisehir Osmangazi University</name>
      <address>
        <city>Eski≈üehir</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>December 24, 2020</study_first_submitted>
  <study_first_submitted_qc>January 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 8, 2021</study_first_posted>
  <last_update_submitted>April 19, 2021</last_update_submitted>
  <last_update_submitted_qc>April 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Inonu University</investigator_affiliation>
    <investigator_full_name>Gulay ERDOGAN KAYHAN</investigator_full_name>
    <investigator_title>Professor, MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

